These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3601530)

  • 41. [Indicators of blood coagulation and fibrinolytic activity of the urine in children with calculous pyelonephritis].
    Kanatbaeva AB; Mazhitova RT; Mustafina SM
    Pediatriia; 1989; (5):22-6. PubMed ID: 2771569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis].
    Zavgorodniĭ LG; Mustiats AP
    Klin Med (Mosk); 1982 Jun; 60(6):74-80. PubMed ID: 7120895
    [No Abstract]   [Full Text] [Related]  

  • 43. [Inhalation method of administering heparin in the combined treatment of glomerulonephritis in children].
    Lebedev VS; Ziablova NP
    Pediatriia; 1988; (11):92. PubMed ID: 3226815
    [No Abstract]   [Full Text] [Related]  

  • 44. [The blood coagulation system in gestational pyelonephritis].
    Spektor GI; Ginzburg LS; Akimova NV; Okuneva EA
    Klin Med (Mosk); 1987 Apr; 65(4):68-71. PubMed ID: 3599862
    [No Abstract]   [Full Text] [Related]  

  • 45. [Heparin electrophoresis by sinusoidal modulated currents in the combined treatment of chronic fetoplacental insufficiency].
    Pronina TA; Bashmakova NV; Shchekoldin PI; Guliaev VIu; Pestriaeva LA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1999; (5):19-22. PubMed ID: 10598524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The coagulation parameters in high-dosage intravenous heparin therapy].
    Weidmann B
    Dtsch Med Wochenschr; 1994 Mar; 119(12):442. PubMed ID: 8143564
    [No Abstract]   [Full Text] [Related]  

  • 47. [Erythrokinetics in chronic pyelonephritis in children].
    Myzina NV; Schastnyĭ SA; Gerasimova IuV
    Urol Nefrol (Mosk); 1975; (3):28-31. PubMed ID: 1162789
    [No Abstract]   [Full Text] [Related]  

  • 48. [Experience with using ultrasonics and methyluracil in the complex treatment of children with non-obstructive pyelonephritis].
    Bozhenov IuA; Ovchinnikova TN; Gliuz AS; Efimov IIu
    Pediatriia; 1989; (2):94-5. PubMed ID: 2726377
    [No Abstract]   [Full Text] [Related]  

  • 49. [Indications and limits of heparin therapy in the hemolytic and uremic syndrome. Literature review apropos of a personal case].
    Cordonnier D; Leger J; Martin H; Guignier M; Debru JL; Franco A; Muller JM
    J Urol Nephrol (Paris); 1970 Sep; 76(9):853-62. PubMed ID: 5482089
    [No Abstract]   [Full Text] [Related]  

  • 50. [Thrombolytic properties of the heparin-tissue plasminogen activator complex and its effect on the fibrinolytic and coagulating systems of the blood in animals].
    Shimonaeva EE; Andreenko GV
    Vopr Med Khim; 1988; 34(1):59-62. PubMed ID: 3130724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of intramuscular administration of heparin in anticoagulant therapy].
    BROUSTET ; POUQUET ; BRICAUD
    J Med Bord; 1954 Apr; 131(4):371-5. PubMed ID: 13184258
    [No Abstract]   [Full Text] [Related]  

  • 52. [Results of the heparin treatment of children with hemorrhagic vasculitis].
    Panchenko MD; Ryneĭskaia VA; Kozarezova TI; Gurevich OE; Artemenko AG
    Pediatriia; 1979 Aug; (8):22-6. PubMed ID: 481995
    [No Abstract]   [Full Text] [Related]  

  • 53. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness of the ozokerite therapy of children with pyelonephritis].
    Smiian IS; Trilinskaia SI; Smiian LV
    Vopr Kurortol Fizioter Lech Fiz Kult; 1977; (2):85-6. PubMed ID: 888390
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapy of pyelonephritis in children].
    Hungerland H
    Acta Paediatr Belg; 1967; 21(2):145-60. PubMed ID: 5595214
    [No Abstract]   [Full Text] [Related]  

  • 56. [Protamine dosage for heparin neutralization in open-heart surgery (author's transl)].
    Shiao K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):878-88. PubMed ID: 4477114
    [No Abstract]   [Full Text] [Related]  

  • 57. [Blood coagulation and excretion of factors of coagulation and fibrinolysis with urine in patients with pyelonephritis].
    Zorina SS
    Klin Med (Mosk); 1975 Mar; 53(3):48-52. PubMed ID: 1117683
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparison of methods for the control of therapy with heparin].
    Jiménez R; Atmetlla F
    Bol Med Hosp Infant Mex; 1975; 32(5):977-83. PubMed ID: 1174439
    [No Abstract]   [Full Text] [Related]  

  • 59. [Anticoagulant treatment with heparin].
    Langer B; Wolosker M; Albers MT
    Rev Paul Med; 1982; 99(1):31-2. PubMed ID: 7146741
    [No Abstract]   [Full Text] [Related]  

  • 60. [Characteristics of the structuro-functional state of cell membranes in children with obstructive pyelonephritis before and after surgical intervention].
    Mlynchik EV; Bankova VV
    Pediatriia; 1988; (11):110-1. PubMed ID: 3226796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.